1. Home
  2. PCVX vs NYT Comparison

PCVX vs NYT Comparison

Compare PCVX & NYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCVX
  • NYT
  • Stock Information
  • Founded
  • PCVX 2013
  • NYT 1851
  • Country
  • PCVX United States
  • NYT United States
  • Employees
  • PCVX N/A
  • NYT N/A
  • Industry
  • PCVX Biotechnology: Pharmaceutical Preparations
  • NYT Newspapers/Magazines
  • Sector
  • PCVX Health Care
  • NYT Consumer Discretionary
  • Exchange
  • PCVX Nasdaq
  • NYT Nasdaq
  • Market Cap
  • PCVX 4.4B
  • NYT 8.6B
  • IPO Year
  • PCVX 2020
  • NYT N/A
  • Fundamental
  • Price
  • PCVX $34.50
  • NYT $56.34
  • Analyst Decision
  • PCVX Strong Buy
  • NYT Buy
  • Analyst Count
  • PCVX 10
  • NYT 5
  • Target Price
  • PCVX $136.50
  • NYT $56.40
  • AVG Volume (30 Days)
  • PCVX 1.5M
  • NYT 1.4M
  • Earning Date
  • PCVX 08-05-2025
  • NYT 08-06-2025
  • Dividend Yield
  • PCVX N/A
  • NYT 1.28%
  • EPS Growth
  • PCVX N/A
  • NYT 21.26
  • EPS
  • PCVX N/A
  • NYT 1.83
  • Revenue
  • PCVX N/A
  • NYT $2,600,814,000.00
  • Revenue This Year
  • PCVX N/A
  • NYT $8.84
  • Revenue Next Year
  • PCVX N/A
  • NYT $5.89
  • P/E Ratio
  • PCVX N/A
  • NYT $30.81
  • Revenue Growth
  • PCVX N/A
  • NYT 6.90
  • 52 Week Low
  • PCVX $27.66
  • NYT $44.83
  • 52 Week High
  • PCVX $121.06
  • NYT $58.16
  • Technical
  • Relative Strength Index (RSI)
  • PCVX 53.91
  • NYT 57.90
  • Support Level
  • PCVX $31.79
  • NYT $56.00
  • Resistance Level
  • PCVX $34.63
  • NYT $57.34
  • Average True Range (ATR)
  • PCVX 1.38
  • NYT 0.88
  • MACD
  • PCVX 0.09
  • NYT 0.05
  • Stochastic Oscillator
  • PCVX 86.31
  • NYT 72.83

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

About NYT New York Times Company (The)

New York Times Co is an American media company known for publishing its flagship newspaper, The New York Times. The company also operates the International New York Times newspaper, as well as digital properties such as NYTimes and various smartphone applications. The company has two segments: New York Times Group and The Athletic. The company generates the majority of its revenue from the NYTG segment. The NYTG and The Athletic segments derive revenue from subscriptions, Advertising, and others, where the majority source of revenue for both segments is subscription.

Share on Social Networks: